SK Bioscience to invest 150 billion won in vaccine factory expansion in Andong

SK Bioscience signed an MOU with Gyeongbuk Province and Andong City to invest about 150 billion won by 2024 to expand production facilities at its L House vaccine factory in Andong, South Korea, and establish new platform facilities for mRNA and next-generation viral vectors.

“SK Bioscience will invest about 150 billion won by 2024, and expand production facilities of L House which has the latest vaccine production facilities”english.makalukhabar.com

• 1 source
• english.makalukhabar.comSK Bioscience to invest 150 billion won in vaccine factory expansion - English.MakaluKhabar.comMakalu KhabarJun 22, 2021

Summarized from public sources; check the original articles before acting on it.